Pfizer Inc Drug Patent Portfolio

Pfizer Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Pfizer Inc News

Q4 Summary of Branded Pharmaceutical Stocks: A Look at Collegium's Performance ... - TradingView

26 Mar, 2026

Novo Nordisk A/S shares encounter FDA alerts regarding GLP-1 medications as competition intensifies.

22 Mar, 2026

FTC Increases Antitrust Scrutiny on Pharmaceutical Industry as Major Drug Patents Near Expiration

18 Mar, 2026

Pfizer Encounters Opportunities and Challenges During Transition | Intellectia.AI

17 Mar, 2026

See More